Literature DB >> 11341034

Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin.

H S Taper1, M B Roberfroid.   

Abstract

Our previously published results indicated that dietary treatment with oligofructose or inulin inhibited malignant tumor growth in experimental animals. Thus it appeared to be interesting to investigate whether the same treatment could have a positive influence on tumor chemotherapy. The chemotherapy-potentiating effect of 15% oligofructose or inulin incorporated into the basal diet for experimental animals was investigated on a transplantable mouse liver tumor. This dietary adjuvant therapy was started seven days before intraperitoneal transplantation of transplantable liver tumor and was continued until the end of experiments. A single, subtherapeutic dose of six different cytotoxic drugs commonly utilized in treatment of human cancer was intraperitoneally injected 48 hours after tumor transplantation. In all experiments, dietary oligofructose or inulin significantly potentiated the therapeutic effects of six different cytotoxic drugs. Such dietary treatment potentiating cancer chemotherapy could be introduced into classical protocols of human cancer treatment as a new, nontoxic, and easily applicable adjuvant cancer therapy without any supplementary risk for patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11341034     DOI: 10.1207/S15327914NC381_1

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  13 in total

Review 1.  Gut microbiota modulation of chemotherapy efficacy and toxicity.

Authors:  James L Alexander; Ian D Wilson; Julian Teare; Julian R Marchesi; Jeremy K Nicholson; James M Kinross
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-08       Impact factor: 46.802

Review 2.  Anticancer effects of the microbiome and its products.

Authors:  Laurence Zitvogel; Romain Daillère; María Paula Roberti; Bertrand Routy; Guido Kroemer
Journal:  Nat Rev Microbiol       Date:  2017-05-22       Impact factor: 60.633

3.  An inulin and doxorubicin conjugate for improving cancer therapy.

Authors:  C A Schoener; B Carillo-Conde; H N Hutson; N A Peppas
Journal:  J Drug Deliv Sci Technol       Date:  2013       Impact factor: 3.981

4.  Immunomodulatory activity of purified arabinoxylans from finger millet (Eleusine coracana, v. Indaf 15) bran.

Authors:  M R Savitha Prashanth; R R Shruthi; G Muralikrishna
Journal:  J Food Sci Technol       Date:  2014-12-11       Impact factor: 2.701

Review 5.  Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.

Authors:  Concetta Panebianco; Angelo Andriulli; Valerio Pazienza
Journal:  Microbiome       Date:  2018-05-22       Impact factor: 14.650

Review 6.  The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?

Authors:  Michela Roberto; Catia Carconi; Micaela Cerreti; Francesca Matilde Schipilliti; Andrea Botticelli; Federica Mazzuca; Paolo Marchetti
Journal:  Front Immunol       Date:  2021-08-20       Impact factor: 7.561

Review 7.  Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy.

Authors:  Yuqing Zhou; Zhaoxia Liu; Tingtao Chen
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

Review 8.  Spot-light on microbiota in obesity and cancer.

Authors:  Paolo Marzullo; Silvia Bettini; Davide Menafra; Sara Aprano; Giovanna Muscogiuri; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes (Lond)       Date:  2021-08-06       Impact factor: 5.095

Review 9.  Drug-Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics.

Authors:  Ali Mohamed; Harry Menon; Marina Chulkina; Nelson S Yee; Irina V Pinchuk
Journal:  Biomedicines       Date:  2021-03-05

Review 10.  Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.

Authors:  Nick Lung-Ngai Ting; Harry Cheuk-Hay Lau; Jun Yu
Journal:  Gut       Date:  2022-03-11       Impact factor: 31.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.